Federated Hermes, Inc. Avidity Biosciences, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 27,134 shares of RNA stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,134

Previous 3,263 731.57%

Holding current value

$1.15 Million

Previous $133,000 836.84%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$37.21 - $48.14 $888,239 - $1.15 Million	23,871 Added 731.57%	27,134 $1.25 Million
Q2 2024 Aug 08, 2024	SELL	$22.73 - $40.85 $1,863 - $3,349	-82 Reduced 2.45%	3,263 $133,000
Q1 2024 May 14, 2024	BUY	$9.16 - $25.52 $30,640 - $85,364	3,345 New	3,345 $85,000
Q3 2023 Nov 13, 2023	BUY	$6.3 - $11.35 $5,934 - $10,691	942 New	942 $6,000
Q4 2022 Feb 13, 2023	SELL	$10.06 - $22.66 $1.15 Million - $2.59 Million	-114,400 Reduced 4.62%	2,363,600 $52.4 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $54,110 - $82,005	3,500 Added 0.14%	2,478,000 $40.5 Million
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $28,559 - $40,124	-1,400 Reduced 0.06%	2,474,500 $58.8 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $9.17 Million - $12.7 Million	504,984 Added 25.62%	2,475,900 $61 Million
Q2 2021 Aug 16, 2021	BUY	$19.62 - $29.26 $3.34 Million - $4.99 Million	170,482 Added 9.47%	1,970,916 $48.7 Million
Q1 2021 May 13, 2021	BUY	$20.28 - $28.15 $7.48 Million - $10.4 Million	368,834 Added 25.76%	1,800,434 $39.3 Million
Q4 2020 Feb 12, 2021	BUY	$24.73 - $35.12 $3.91 Million - $5.55 Million	158,000 Added 12.41%	1,431,600 $36.5 Million
Q3 2020 Nov 12, 2020	BUY	$23.35 - $35.94 $21.1 Million - $32.4 Million	902,681 Added 243.36%	1,273,600 $35.9 Million
Q2 2020 Aug 13, 2020	BUY	$26.62 - $31.5 $9.87 Million - $11.7 Million	370,919 New	370,919 $10.5 Million

Others Institutions Holding RNA

# of Institutions

256

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.22B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Avidity Biosciences, Inc. Transaction History